22 Tex. Admin. Code § 111.4 - Prescription Monitoring by the Board
(a)
The Board shall promulgate specific guidelines for dentists for the responsible
prescribing of opioids, benzodiazepines, barbiturates, or
carisoprodol.
(b) The Board shall
periodically access a dentist's prescription information through the
Prescription Monitoring Program to determine whether they are engaging in
potentially harmful prescribing patterns or practices. This determination will
be based on:
(1) the number of times a
dentist prescribes opioids, benzodiazepines, barbiturates, or carisoprodol;
and
(2) patterns of prescribing
combinations of those drugs and other dangerous combinations identified by the
Texas State Board of Pharmacy.
(c) The Board shall notify a dentist if the
agency discovers that the dentist may be engaging in potentially harmful
prescribing patterns or practices.
(d) The Board may open a complaint against a
dentist if the agency finds evidence during a periodic check that the dentist
is engaging in conduct that violates any laws or rules related to the practice
of dentistry.
(e) This rule is
effective on September 1, 2019, in accordance with H.B. 2561 of the 85th Texas
Legislature.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.